Deutsche Bank’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Deutsche Bank’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2	Closed	-$1K	–	5165
2017 Q2	$1K	Buy	+2	New	+$1.17K	﹤0.01%	4883
2016 Q2	–	Sell	-81	Closed	-$34K	–	5401
2016 Q1	$34K	Buy	81 +34	+72%	+$12.7K	﹤0.01%	4452
2015 Q4	$23K	Buy	+47	New	+$34K	﹤0.01%	4721
2015 Q3	–	Sell	-53	Closed	-$92K	–	5398
2015 Q2	$92K	Buy	+53	New	+$82.4K	﹤0.01%	4280

Other funds holding VYNT

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FCM

Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

Deutsche Bank's VYNT Position: Q3 2017 in Review

Deutsche Bank sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2017, closing a stake of 2 shares — an estimated $1K sold.

Deutsche Bank first reported a position in VYNT in Q2 2015 and held it in 4 quarters. The position peaked at $92K in Q2 2015. 26 funds tracked by Wall St. Rank hold VYNT as of Q3 2017.

Deutsche Bank reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Deutsche Bank sold 2 Vyant Bio, Inc. Common Stock shares in Q3 2017, an estimated $1K.
Deutsche Bank first reported a position in Vyant Bio, Inc. Common Stock in Q2 2015 and held it in 4 quarters.
Deutsche Bank's Vyant Bio, Inc. Common Stock position peaked at $92K in Q2 2015.
26 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2017.

Based on Deutsche Bank's 13F filing for Q3 2017, filed 14 Nov 2017.